India  

Govt must explain why international protocols were disregarded to approve Bharat Biotech’s Covaxin, Congress leaders say

IndiaTimes Sunday, 3 January 2021 ()
0
shares
ShareTweetSavePostSend
 
Video Credit: HT Digital Content - Published
News video: 'Who will opt for vaccine...': Congress questions approval, slams govt

'Who will opt for vaccine...': Congress questions approval, slams govt 03:25

Congress leader Manish Tewari alleged that the union government has 'politically misused pandemic in its entirety'. Tewari also slammed the Centre over the grant of approval to Bharat Biotech's Covid vaccine. The congress leader, however, did not name the Hyderabad-based company. On Sunday, DCGI...

💡 newsR Knowledge: Other News Mentions

Bharat Biotech Bharat Biotech Indian biotechnology company and vaccine manufacturer

Covid vaccine: How many Indians got jab on Day 1? Govt reveals [Video]

Covid vaccine: How many Indians got jab on Day 1? Govt reveals

At least 1,65,714 healthcare beneficiaries received COVID-19 jab on Saturday across India, marking it as a historic and biggest COVID-19 vaccination drive launched by Prime Minister Narendra Modi. About 16,755 total vaccinators involved across India during the COVID vaccination drive. There was no post adverse event reported after the vaccination was administered to the people. "Total vaccinators involved across India were 16,755. Total beneficiaries vaccinated across India--1,65,714. COVID19 vaccination drive was successful on Day 1. No case of post-vaccination hospitalisation reported so far," said Manohar Agnani, Additional Secretary of Union Health Ministry. "The Serum Institute of India (SII) produced COVISHIELD was supplied to all States and Union Territories (UT). Bharat Biotech's COVAXIN was supplied to 12 States. Total 3,351 sessions were held across the country with both the vaccines, said Health Ministry on COVID19 vaccine roll-out," he added. Watch the full video for more details.

Credit: HT Digital Content    Duration: 06:46Published
First feeling, side-effects, doubts: Vaccinated doctors share experience [Video]

First feeling, side-effects, doubts: Vaccinated doctors share experience

On Day 1 of India's Covid-19 vaccination, two doctors who took the shots shared their experience. Dr Atul Peters and Anil Dhar of Max hospital were given Bharat Biotech's Covaxin and SII-made Covishield jabs respectively. Both didn't experience any side-effects and said that doubts regarding the inoculants are unfounded. Dr Suranjit Chatterjee of Apollo hospital, who is set to receive a shot soon, also weighed in on the controversy regarding Covaxin and its third phase trials. Watch the full video for more.

Credit: HT Digital Content    Duration: 08:15Published
Covid: Dr VK Paul, AIIMS director urge people to trust researchers on vaccine [Video]

Covid: Dr VK Paul, AIIMS director urge people to trust researchers on vaccine

Urging the people to have faith in India's researchers, scientists, regulatory authorities, All India Institute of Medical Sciences (AIIMS) Director Dr Randeep Singh Guleria on Saturday reassured the nation that Bharat Biotech's COVAXIN vaccine is safe. Dr Guleria along with NITI Aayog member VK Paul were administered the COVID-19 vaccine shot at AIIMS Delhi on the inaugural day of the nationwide roll-out of vaccination on Saturday. Talking about the experience, he said, "I am humbled to get vaccinated in the first slot and feel so proud. I hope more and more people come forward when it comes to getting vaccinated so that we can reduce mortality and prevent the spread of COVID-19 infection." Dr VK Paul said that the vaccine is safe and people should trust the scientific process. Watch the full video for more details.

Credit: HT Digital Content    Duration: 03:41Published

United States Congress United States Congress Legislature of the United States

Will poor and underprivileged get Covid-19 vaccine for free? Asks Congress

A day after India rolled out the world's largest inoculation drive against Covid-19, the Congress on Sunday asked the government whether it plans to provide free..
IndiaTimes
Biden plans flurry of Day One executive actions [Video]

Biden plans flurry of Day One executive actions

The promised executive actions to be taken on Day One include policy changes on housing, student loans, climate change and immigration. This report produced by Jonah Green.

Credit: Reuters - Politics    Duration: 01:27Published
FBI questions dozens in Capitol police killing: NYT [Video]

FBI questions dozens in Capitol police killing: NYT

The FBI is questioning dozens of people in the killing of Brian Sicknick, a police officer who died a day after physically engaging with a mob of supporters of President Donald Trump who stormed the U.S. Capitol last week, and other assaults on law enforcement, the New York Times reported on Friday. Gloria Tso has more.

Credit: Reuters - Politics    Duration: 01:15Published

You Might Like


Related videos from verified sources

Covid vaccine: Congress minister's appeal to Modi govt after Jan 16 launch move [Video]

Covid vaccine: Congress minister's appeal to Modi govt after Jan 16 launch move

On the day that the Union government announced the launch date of Covid-19 vaccination in the country, Chhattisgarh health minister TS Singh Deo made an appeal. The Congress leader said that the Centre..

Credit: HT Digital Content     Duration: 03:58Published
Just for 'Atmanirbhar Bharat', govt licensed Covaxin despite pending trials: Manish Tewari [Video]

Just for 'Atmanirbhar Bharat', govt licensed Covaxin despite pending trials: Manish Tewari

: Congress leader Manish Tewari slammed Centre for licensing the Bharat Biotech's vaccine candidate for COVID-19, Covaxin, despite the final phase trials not being completed. "The BJP government has..

Credit: ANI     Duration: 01:36Published
Congress raises concerns over approval given to Bharat Biotech's Covaxin vaccine| Oneindia News [Video]

Congress raises concerns over approval given to Bharat Biotech's Covaxin vaccine| Oneindia News

Hours after India's drug regulator approved indigenously developed 'Covaxin' of Bharat Biotech, Congress leaders raised concern over the grant of permission for the restricted use of Covaxin without..

Credit: Oneindia     Duration: 01:22Published

Related news from verified sources

Will resign as Maharashtra Congress chief if party wants: Balasaheb Thorat

Amid speculations over resignation during his Delhi visit, Maharashtra Congress President Balasaheb Thorat said on Tuesday he will be ready to resign if the...
Mid-Day

Congress set to call meet of senior leaders to discuss party revamp

Congress is set to call a meeting of senior leaders to discuss organisational overhaul and to follow up on the discussion held earlier in December. It is learnt...
IndiaTimes

Congress sees BJP’s role in Ramateertham incident

Andhra Pradesh Congress Coordination Committee member Sunkara Padmasri on Sunday criticised the ruling YSR Congress Party and the Opposition TDP for r
Hindu Also reported by •IndiaTimes